Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High dose Risperdal Consta in schizophrenia
NCT00539071Phase 4Completed
- Sponsor
- Northwestern University
- Start
- Mar 2008
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in schizophrenia, schizoaffective disorder, sponsored by Northwestern University. Started Mar 2008; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00539071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539071.